Weekly shot tested to tame tough 'Double Diabetes'
NCT ID NCT05305794
Summary
This study is testing if a weekly injection called semaglutide can help adults who have features of both type 1 and type 2 diabetes, a condition sometimes called 'double diabetes.' The goal is to see if the drug can make the body respond better to insulin and improve blood sugar control. Participants will be randomly assigned to receive either the weekly injection alongside their usual insulin therapy or to continue with their usual insulin therapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DOUBLE DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.